Shutterstock
Dr. Uwe Hanenberg, Head of Product Development, Oral Solid Dose and Dr. Maria Lundin-Johnson, Head of Formulation Development, at Recipharm, explore the current trends influencing the oral solid dose (OSD) market and the significant challenges they present to the advancement of medicines.